Immunomedics (IMMU) –
-
Mendus AB: Mendus presents positive survival data from the ADVANCE II trial evaluating DCP-001 as a maintenance therapy in AML at the American Society of Hematology (ASH) meeting
-
FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial cancer
-
Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors
-
Form 15-12G IMMUNOMEDICS INC
-
Form EFFECT IMMUNOMEDICS INC
-
Form EFFECT IMMUNOMEDICS INC
-
Form EFFECT IMMUNOMEDICS INC
-
Form EFFECT IMMUNOMEDICS INC
-
Form EFFECT IMMUNOMEDICS INC
-
Form EFFECT IMMUNOMEDICS INC
-
Form EFFECT IMMUNOMEDICS INC
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Fricker William
-
Form S-8 POS IMMUNOMEDICS INC
-
Form S-8 POS IMMUNOMEDICS INC
-
Form S-8 POS IMMUNOMEDICS INC
-
Form S-8 POS IMMUNOMEDICS INC
-
Form S-8 POS IMMUNOMEDICS INC
-
Form S-8 POS IMMUNOMEDICS INC
-
Form S-8 POS IMMUNOMEDICS INC
-
Form S-8 POS IMMUNOMEDICS INC
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Malik Usama
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Aghazadeh Behzad
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Canute Scott A
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Azelby Robert
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: ITRI LORETTTA M
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: HUTT PETER BARTON
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Andrews Kurt J.
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Delaney Brendan
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Islam Khalid
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Freedberg Jared
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: BALL BRYAN
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: Duncan Barbara Gayle
-
Form 4 IMMUNOMEDICS INC For: Oct 23 Filed by: BAUM CHARLES M
-
Form SC 13D/A IMMUNOMEDICS INC Filed by: Avoro Capital Advisors LLC
-
Form POS AM IMMUNOMEDICS INC
-
Form POS AM IMMUNOMEDICS INC
-
Form POS AM IMMUNOMEDICS INC
-
Form POS AM IMMUNOMEDICS INC
-
Form POS AM IMMUNOMEDICS INC
-
Form POS AM IMMUNOMEDICS INC
-
Form POS AM IMMUNOMEDICS INC
-
Form 8-K IMMUNOMEDICS INC For: Oct 23
-
Gilead Sciences (GILD) Completes Acquisition of Immunomedics (IMMU)
-
Gilead Sciences Completes Acquisition of Immunomedics, Inc.
-
Form 25-NSE IMMUNOMEDICS INC Filed by: The Nasdaq Stock Market LLC
-
Form SC 14D9/A IMMUNOMEDICS INC Filed by: IMMUNOMEDICS INC
-
Form SC TO-T/A IMMUNOMEDICS INC Filed by: GILEAD SCIENCES INC
-
ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics
-
Form SC TO-T/A IMMUNOMEDICS INC Filed by: GILEAD SCIENCES INC
-
Form SC 14D9/A IMMUNOMEDICS INC Filed by: IMMUNOMEDICS INC
Back to IMMU Stock Lookup